Identification of novel SIRT1 up-regulators using a cell-based high-throughput screening assay

Yanjia Shen(Chinese Academy of Medical Sciences & Peking Union Medical College), Haiguang Yang(Tongji University), Qizhi Cao(Binzhou Medical University), Wendan Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Gao(Army Medical University), Huilin Yang(Soochow University), Guanhua Du(Shanghai Jiao Tong University)
European Journal of Pharmacology
August 15, 2025
10.1016/j.ejphar.2025.178066
Cited by 0

Related Papers

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
SIRT1 Acts as a Modulator of Neointima Formation Following Vascular Injury in Mice
|Circulation Research|2011|183
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
|Biochemical Pharmacology|2020|160
Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis
|BMC Medicine|2012|139
Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells
|Free Radical Biology and Medicine|2017|136